Hologic challenges KV over Makena - Medical Marketing and Media

11/01/12

Hologic challenges KV over Makena
Medical Marketing and Media
The swirl of paper surrounding KV Pharmaceuticals' request for Chapter 11 bankruptcy protection continues to grow. At the center of the proceedings is the controversy surrounding Makena, a drug approved for the prevention of premature birth. Hologic ...